中国专家关于肝细胞癌新辅助和转化疗法的共识:2023年更新
Xinyu Bi1, Haitao Zhao2, Hong Zhao1
1Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liver cancer
|April 21, 2025
概括
新辅助和转化疗法可以改善肝细胞癌 (HCC) 患者的外科切除率. 这个更新的2023年共识提供了指导,以加强治疗策略和减少中等到高级HCC的复发.
科学领域:
- 肝胆道手术是肝胆道的手术.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 在中国面临挑战,复发率高,切除率低.
- 术前治疗,如新辅助药和转化疗法,提供了潜在的解决方案.
- 一个更新的2023年共识解决了这些疗法在HCC管理中的新证据.
研究的目的:
- 提供最新的临床指导,用于新辅助药和转化疗法在HCC.
- 概述原则,患者选择,治疗方法和多学科团队角色.
- 为 HCC 术前治疗的未来研究方向提供信息.
主要方法:
- 由多学科专家小组共同制定共识.
- 审查和整合关于HCC新辅助药和转换疗法的新兴证据.
- 制定结构化的指导方针,涵盖手术前治疗的关键方面.
主要成果:
- 2023年的共识为HCC手术前治疗策略提供了更新的建议.
- 它强调优化患者选择和治疗方式.
- 共识强调了多学科团队方法的重要性.
结论:
- 新辅助和转化疗法可以增加中等到高级HCC的切除率.
- 这些策略旨在减少HCC复发并改善患者生存结果.
- 该共识为中国的临床应用和未来研究提供了一个框架.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.0K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
